Remove topics therapeutic-goods-act
article thumbnail

UK’s short-lived dream for a code of practice on genAI and copyright law

Kluwer Copyright Blog

The mandate of the group was to identify, develop and codify good practice on the use of copyright, performance and database material in relation to AI, including data mining. Copyright law has always been an emotional topic. Processing this amount of data is a heavy task for policy-makers, but it is equally good news.

article thumbnail

Supreme Court on Patent Law for October 2022

Patently-O

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) : 1 Case; Procedure / Standing: 6 Cases; Eligibility ( AmAxle Redux): 3 Cases; and. Full Scope Written Description in Juno Therapeutics, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Look Back at India’s Top IP Developments of 2021

SpicyIP

This year, we have divided these developments into three categories: a) Top 10 IP Judgments/Orders (Topicality/Impact). Top 10 Judgments/Orders [Topicality/Impact]. Both suits were filed before the 2012 amendment to the Copyright Act. b) Top 10 IP Judgments/Orders (Jurisprudence/Legal Lucidity) and. H Lundbeck A/S v.

IP 143
article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

Litigation under the Biologics Price Competition and Innovation Act (BPCIA) in the district courts also decreased. In the guidance documents, FDA provides “answers to common questions from prospective applicants and other interested parties regarding the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).”

article thumbnail

Monthly Wrap Up (March 12, 2023): Noteworthy Trade Secret and Restrictive Covenant Cases, Developments and Posts

LexBlog IP

16, 2023), the vendor GateGuard alleged that Amazon was misappropriating GateGuard’s “proprietary security technology that acts as an ‘AI Doorman’ for multifamily residential properties, allowing authorized users to unlock entrances remotely and to monitor activity.” dismissing Sherman Act claims), and the U.S.

article thumbnail

The Intersection of Artificial Intelligence (AI), Life Sciences, Healthcare, and Intellectual Property (IP)

LexBlog IP

“These types of models can enable fast evaluation of medical device settings and patient-selection criteria, as well as the development of novel therapeutic agents,” she explained. The National Library of Medicine (NLM) has also reported on the topic of AI in radiotherapy , where AI can be applied to images (e.g.,